Controlling the HIV epidemic with antiretrovirals: IAPAC consensus statement on treatment as prevention and preexposure prophylaxis (Q38105957)

28 August 2017

Controlling the HIV epidemic with antiretrovirals: IAPAC consensus statement on treatment as prevention and preexposure prophylaxis (English)

1 reference

28 August 2017

anti-retroviral agent

0 references

prevention of HIV/AIDS

0 references

1 reference

5

1 reference

28 August 2017

15

Helen Rees

1 reference

28 August 2017

K Rivet Amico

4

0 references

Julio Montaner

14

object named as

Julio S G Montaner

1 reference

28 August 2017

1

Kenneth Mayer

1 reference

28 August 2017

16

Bruce Schackman

1 reference

28 August 2017

Brian Gazzard

2

1 reference

28 August 2017

José M Zuniga

3

1 reference

28 August 2017

Yusef Azad

6

1 reference

28 August 2017

Gus Cairns

7

1 reference

28 August 2017

Nikos Dedes

8

1 reference

28 August 2017

Chris Duncombe

9

1 reference

28 August 2017

Sarah J Fidler

10

1 reference

28 August 2017

Reuben Granich

11

1 reference

28 August 2017

Michael A Horberg

12

1 reference

28 August 2017

Sheena McCormack

13

1 reference

28 August 2017

Papa Salif Sow

17

1 reference

28 August 2017

International Association of Physicians in AIDS Care

18

1 reference

28 August 2017

1 May 2013

1 reference

Journal of the International Association of Providers of AIDS Care

28 August 2017

1 reference

28 August 2017

12

1 reference

28 August 2017

3

1 reference

28 August 2017

208-216

1 reference

Prevention of HIV-1 infection with early antiretroviral therapy

28 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F2325957413475839

Breakthrough of the year. HIV treatment as prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2325957413475839

Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2325957413475839

Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2325957413475839

Stable incidence of HIV diagnoses among Danish MSM despite increased engagement in unsafe sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2325957413475839

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2325957413475839

Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2325957413475839

The effect of antiretroviral therapy on secondary transmission of HIV among men who have sex with men

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2325957413475839

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2325957413475839

The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2325957413475839

Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2325957413475839

Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2325957413475839

Antiretroviral prophylaxis: a defining moment in HIV control

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2325957413475839

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2325957413475839

Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2325957413475839

HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2325957413475839

The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2325957413475839

Evaluating the cost-effectiveness of pre-exposure prophylaxis (PrEP) and its impact on HIV-1 transmission in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2325957413475839

The cost-effectiveness of pre-exposure prophylaxis for HIV infection in South African women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2325957413475839

A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2325957413475839

21 January 2018

Identifiers

DOI

10.1177/2325957413475839

1 reference

28 August 2017

1 reference